✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹29,995 Cr.
P/E
59.81
About
Syngene International Limited, founded in 1993, is a globally recognized contract research and manufacturing firm. It offers a wide range of services supporting research and development projects, from… Read more
Syngene International Limited, founded in 1993, is a globally recognized contract research and… Read more
Low
608
52W Range
High
961
  • Syngene Internation.
  • Piramal Pharma
  • Laurus Labs
  • TJI Pharma - API & CRAMS

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

11 Yes

Positive for this company

1 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison
Suppliers
  • HLE Glascoat Ltd.
Customers
  • Procter & Gamble Health Ltd.
  • Amgen
  • Bristol-Myers Squibb
  • Abbvie
  • Albireo
FAQs on Syngene International Ltd. Business

Syngene International Limited, established in 1993, is a renowned CRMO offering integrated drug discovery and development services. With various certifications and accreditations, the company provides support from lead generation to clinical supplies.

Syngene Internation. major competitors are Piramal Pharma, Laurus Labs, Sun Pharma Adv. Res, Dishman Carbogen Amc, Zenotech Laboratorie, Jeevan Scientific, Vivo Bio Tech.
Market Cap of Syngene Internation. is ₹30,017 Crs.
While the median market cap of its peers are ₹3,876 Crs.

Syngene Internation. seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Dec Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material